Clinical Trial Update: XELOX for Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for XELOX in metastatic breast cancer (completed).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• XELOX (capecitabine + oxaliplatin)

Snippet

Sponsor: University of Wisconsin, Madison | Conditions: Metastatic Breast Cancer | Phase 2 | Status: COMPLETED